Christopher R. Fenimore
EVP Finance CFO · 1 filing · Latest: Aug 18, 2026
REGENERON PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
REGN | Christopher R. Fenimore | EVP Finance CFO | Aug 18, 2026 | Option Exercise | $381.92 | 6,283 | $2.4M | 24,583 | |
REGN | Christopher Fenimore | — | Aug 28, 2024 | Proposed Sale | $1,205.21 | 5,680 | $6.8M | — | |